Figure 5. Covalent modification of LYPLA1 by Probe ML211 (Compound 1.18, SID 99445338).

Figure 5Covalent modification of LYPLA1 by Probe ML211 (Compound 1.18, SID 99445338)

Active Site Peptide: R.IILGGFS114QGGALSLYTALTTQQK.L

From: Optimization and characterization of a triazole urea dual inhibitor for lysophospholipase 1 (LYPLA1) and lysophospholipase 2 (LYPLA2)

Cover of Probe Reports from the NIH Molecular Libraries Program
Probe Reports from the NIH Molecular Libraries Program [Internet].

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.